4.6 Article

Impact of NOTCH1 polymorphisms on liver cancer in a Chinese Han population

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

PIK3R3 Missense and NOTCH2 Synonymous Single Nucleotide Polymorphisms Are Associated with Liver Cancer

Baofeng Wang et al.

Summary: This study mainly investigated the effects of PIK3R3 and NOTCH2 gene polymorphisms on the risk of liver cancer in Chinese people. The results demonstrated that the PIK3R3-rs785467 and NOTCH2-rs3795666 polymorphisms decreased the susceptibility to liver cancer.

DIGESTIVE DISEASES (2023)

Article Gastroenterology & Hepatology

Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy

Tianyi Liang et al.

Summary: This retrospective cohort study found that male patients have a higher risk of hepatocellular carcinoma (HCC) recurrence after curative hepatectomy compared to females.

ANNALS OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

PIK3R3 missense and NOTCH2 synonymous single nucleotide polymorphisms are associated with liver cancer

Baofeng Wang et al.

Summary: This study investigated the effects of PIK3R3 and NOTCH2 gene polymorphisms on the risk of liver cancer among Chinese Han population. The results showed that PIK3R3-rs785467 and NOTCH2-rs3795666 polymorphisms decreased the susceptibility to liver cancer.

DIGESTIVE DISEASES (2022)

Article Multidisciplinary Sciences

Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity

Zahraa I. Khamis et al.

Summary: Liver cancer burden is higher in Asian Americans compared to Caucasian Americans, and understanding genetic differences is crucial for personalized treatment. Analysis of RNA-seq data revealed differential expression of the CYP2D6 gene in Asian Americans, potentially serving as a biomarker for liver cancer health disparities. Further investigation into the relationship between CYP2D6 and inflammation may help improve detection, diagnosis, surveillance, and treatment of liver cancer in vulnerable populations.

PLOS ONE (2021)

Article Gastroenterology & Hepatology

Current epidemiology in hepatocellular carcinoma

Peter Konyn et al.

Summary: This review discusses the risk factors, global trends, and high incidence rates of HCC in Asia and Africa. Interventions to minimize the global burden of HCC include reducing common risk factors, treating underlying causes effectively, and implementing comprehensive screening programs for HCC. Healthcare inequity is identified as a crucial area for improvement in addressing disparities in HCC incidence and mortality among racial and ethnic minorities in multiethnic countries.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Oncology

Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis

Divya Jain et al.

Summary: Smoking produces over 4000 chemicals that harm every part of the human body, with specific severe effects on the liver. It leads to cytotoxic substances, chronic liver injury, and increases the risk of liver cancer, while also impacting immune responses and interfering with hepatitis C therapy responses. Efforts to reduce smoking prevalence aim to improve public health and reduce premature death.

JOURNAL OF ONCOLOGY (2021)

Article Medicine, Research & Experimental

TP53 rs28934571 polymorphism increases the prognostic risk in hepatocellular carcinoma

Yichao Zhao et al.

Summary: This study investigated the relationship between TP53 rs28934571 polymorphism and HCC risk in Guangxi, China, suggesting that allele A on TP53 rs28934571 may be a risk factor for HCC and mutation from C to A could increase the risk of poor prognosis of HCC. It concluded that TP53 rs28934571 may serve as a diagnostic indicator for judging the prognosis of HCC.

BIOMARKERS IN MEDICINE (2021)

Article Oncology

EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma

Jia Wang et al.

Summary: The EGF rs4444903 polymorphism does not significantly increase the risk of HBV/HCV, but is associated with increased risk of liver cirrhosis and HCC, particularly among Asians and Caucasians. Larger studies with diverse ethnic populations are needed to confirm these findings.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study

Harriet Rumgay et al.

Summary: Alcohol use is causally linked to multiple cancers globally, with 741,300 new cancer cases attributable to alcohol consumption in 2020. Male accounted for the majority of alcohol-attributable cancer cases, with heavy drinking and risky drinking contributing most to the burden. Regional variations exist in the burden of alcohol-attributable cancers.

LANCET ONCOLOGY (2021)

Article Genetics & Heredity

Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study

Minxian Wang et al.

Summary: The study suggests that polymorphisms in vitamin family genes CYP24A1 and CYP27B1 may be associated with the risk of NAFLD, with patients carrying multiple unfavorable alleles having a significantly higher risk of NAFLD.

FRONTIERS IN GENETICS (2021)

Article Oncology

NOTCH Single Nucleotide Polymorphisms in the Predisposition of Breast and Colorectal Cancers in Saudi Patients

Ibrahim O. Alanazi et al.

Summary: Breast cancer and colorectal cancer are common malignancies with various genetic alterations in signaling pathway genes. Specific single nucleotide polymorphisms in NOTCH genes were found to be associated with susceptibility to these cancers in the Saudi population. Further validation in larger populations of different ethnicities could potentially identify these SNPs as genetic screening markers for early detection of breast and colorectal carcinomas.

PATHOLOGY & ONCOLOGY RESEARCH (2021)

Article Multidisciplinary Sciences

Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity

Zahraa I. Khamis et al.

Summary: Liver cancer burden is higher in Asian Americans compared to Caucasian Americans, potentially due to genetic differences. Analysis of RNA-seq data identified CYP2D6 as a gene with higher expression in Asian Americans, suggesting it may serve as a putative biomarker for liver cancer health disparities. Further research is needed to understand the intricate relationship between genetic factors, inflammation, and ethnic differences in liver cancer patients.

PLOS ONE (2021)

Review Pharmacology & Pharmacy

Notch1 in Cancer Therapy: Possible Clinical Implications and Challenges

L. Gharaibeh et al.

MOLECULAR PHARMACOLOGY (2020)

Review Gastroenterology & Hepatology

Disease Burden of Hepatocellular Carcinoma: A Global Perspective

Mehmet Sayiner et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Article Genetics & Heredity

Predicting functional variants in enhancer and promoter elements using RegulomeDB

Shengcheng Dong et al.

HUMAN MUTATION (2019)

Article Gastroenterology & Hepatology

Epidemiology and Management of Hepatocellular Carcinoma

Laura Kulik et al.

GASTROENTEROLOGY (2019)

Article Biochemistry & Molecular Biology

Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a

Xiaoru Xin et al.

MOLECULAR CANCER (2018)

Article Oncology

Cancer Statistics in China, 2015

Wanqing Chen et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Gastroenterology & Hepatology

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

Joong-Won Park et al.

LIVER INTERNATIONAL (2015)

Article Dermatology

NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis

Andrew P. South et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Review Developmental Biology

Developmental gene regulation in the era of genomics

Julia Zeitlinger et al.

DEVELOPMENTAL BIOLOGY (2010)

Article Developmental Biology

Notch signaling controls liver development by regulating biliary differentiation

Yiwei Zong et al.

DEVELOPMENT (2009)